Literature DB >> 14523776

Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication.

Karen A Wendel1, Justin C McArthur.   

Abstract

We describe 3 patients with chronic human immunodeficiency virus (HIV) infection who presented with syndromes compatible with acute meningoencephalitis secondary to HIV; these syndromes were characterized by elevated cerebrospinal spinal fluid (CSF) HIV viral loads and T2-weighted signal abnormalities on magnetic resonance imaging of the brain. After the initiation of or a change in highly active antiretroviral therapy (HAART), each of the patients had significant and rapid improvement in neurologic symptoms and dramatic reductions in CSF HIV viral loads. Although further investigation is needed, these findings suggest that measurement of CSF HIV viral load and treatment with central nervous system-penetrating HAART should be considered for patients with acute neurologic complaints, chronic HIV infection, and no other identifiable cause of neurologic illness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523776     DOI: 10.1086/378300

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Neuropsychiatric complications of antiretroviral therapy.

Authors:  Michelle S Cespedes; Judith A Aberg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.

Authors:  Dianne Langford; Jennifer Marquie-Beck; Sergio de Almeida; Deborah Lazzaretto; Scott Letendre; Igor Grant; J Allen McCutchan; Eliezer Masliah; Ronald J Ellis
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools.

Authors:  Victor G Valcour
Journal:  Top Antivir Med       Date:  2011-12

Review 4.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford; Beau M Ances
Journal:  Lancet Infect Dis       Date:  2013-11       Impact factor: 25.071

Review 5.  Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Authors:  Francesca Ferretti; Magnus Gisslen; Paola Cinque; Richard W Price
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

6.  Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.

Authors:  Christina Patrick; Leslie Crews; Paula Desplats; Wilmar Dumaop; Edward Rockenstein; Cristian L Achim; Ian P Everall; Eliezer Masliah
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 7.  HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies.

Authors:  Phillip Chan; Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2022-05-10       Impact factor: 5.071

Review 8.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

9.  Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up.

Authors:  S Villar del Saz; O Sued; V Falcó; F Agüero; M Crespo; T Pumarola; A Curran; J M Gatell; A Pahissa; J M Miró; E Ribera
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

Review 10.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.